VERIFYME INC (VRME) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:VRME • US92346X2062

1.07 USD
+0.1 (+10.3%)
At close: Feb 6, 2026
1.1 USD
+0.03 (+2.8%)
After Hours: 2/6/2026, 8:10:49 PM
Fundamental Rating

3

VRME gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 123 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of VRME is average, but there are quite some concerns on its profitability. VRME is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year VRME has reported negative net income.
  • In the past year VRME had a positive cash flow from operations.
  • In the past 5 years VRME reported 4 times negative net income.
  • In multiple years VRME reported negative operating cash flow during the last 5 years.
VRME Yearly Net Income VS EBIT VS OCF VS FCFVRME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • VRME has a Return On Assets of -35.58%. This is in the lower half of the industry: VRME underperforms 78.05% of its industry peers.
  • With a Return On Equity value of -42.50%, VRME is not doing good in the industry: 73.17% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -35.58%
ROE -42.5%
ROIC N/A
ROA(3y)-36.52%
ROA(5y)-32.04%
ROE(3y)-56.82%
ROE(5y)-44.86%
ROIC(3y)N/A
ROIC(5y)N/A
VRME Yearly ROA, ROE, ROICVRME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

  • VRME's Gross Margin of 34.94% is in line compared to the rest of the industry. VRME outperforms 55.28% of its industry peers.
  • VRME's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for VRME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.64%
GM growth 5Y-15.56%
VRME Yearly Profit, Operating, Gross MarginsVRME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

5

2. Health

2.1 Basic Checks

  • VRME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VRME has been increased compared to 1 year ago.
  • The number of shares outstanding for VRME has been increased compared to 5 years ago.
  • VRME has a worse debt/assets ratio than last year.
VRME Yearly Shares OutstandingVRME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
VRME Yearly Total Debt VS Total AssetsVRME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • VRME has an Altman-Z score of -3.83. This is a bad value and indicates that VRME is not financially healthy and even has some risk of bankruptcy.
  • VRME has a Altman-Z score of -3.83. This is in the lower half of the industry: VRME underperforms 79.67% of its industry peers.
  • The Debt to FCF ratio of VRME is 1.96, which is an excellent value as it means it would take VRME, only 1.96 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of VRME (1.96) is better than 78.05% of its industry peers.
  • VRME has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.07, VRME is in line with its industry, outperforming 56.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.96
Altman-Z -3.83
ROIC/WACCN/A
WACC9.57%
VRME Yearly LT Debt VS Equity VS FCFVRME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 3.70 indicates that VRME has no problem at all paying its short term obligations.
  • VRME has a Current ratio of 3.70. This is in the better half of the industry: VRME outperforms 71.54% of its industry peers.
  • VRME has a Quick Ratio of 3.69. This indicates that VRME is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of VRME (3.69) is better than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 3.69
VRME Yearly Current Assets VS Current LiabilitesVRME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

3

3. Growth

3.1 Past

  • The earnings per share for VRME have decreased strongly by -22.58% in the last year.
  • The Revenue for VRME has decreased by -14.21% in the past year. This is quite bad
  • Measured over the past years, VRME shows a very strong growth in Revenue. The Revenue has been growing by 151.62% on average per year.
EPS 1Y (TTM)-22.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y203.02%
Revenue growth 5Y151.62%
Sales Q2Q%-7.4%

3.2 Future

  • Based on estimates for the next years, VRME will show a very strong growth in Earnings Per Share. The EPS will grow by 21.68% on average per year.
  • VRME is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -17.34% yearly.
EPS Next Y27.75%
EPS Next 2Y28.29%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue Next Year-23.19%
Revenue Next 2Y-15.77%
Revenue Next 3Y-17.34%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRME Yearly Revenue VS EstimatesVRME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M 25M
VRME Yearly EPS VS EstimatesVRME Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

  • VRME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRME. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VRME Price Earnings VS Forward Price EarningsVRME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

  • VRME's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, VRME is valued a bit cheaper than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.85
EV/EBITDA 24.74
VRME Per share dataVRME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • VRME's earnings are expected to grow with 21.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.29%
EPS Next 3Y21.68%

0

5. Dividend

5.1 Amount

  • No dividends for VRME!.
Industry RankSector Rank
Dividend Yield 0%

VERIFYME INC

NASDAQ:VRME (2/6/2026, 8:10:49 PM)

After market: 1.1 +0.03 (+2.8%)

1.07

+0.1 (+10.3%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-14
Earnings (Next)03-04
Inst Owners8.11%
Inst Owner Change1.47%
Ins Owners18.98%
Ins Owner Change-0.83%
Market Cap13.31M
Revenue(TTM)21.67M
Net Income(TTM)-4.72M
Analysts85
Price Target1.53 (42.99%)
Short Float %16.19%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-196.3%
Min EPS beat(2)-466.45%
Max EPS beat(2)73.86%
EPS beat(4)2
Avg EPS beat(4)-100.67%
Min EPS beat(4)-466.45%
Max EPS beat(4)73.86%
EPS beat(8)5
Avg EPS beat(8)-37.18%
EPS beat(12)8
Avg EPS beat(12)-18.83%
EPS beat(16)10
Avg EPS beat(16)-31.35%
Revenue beat(2)2
Avg Revenue beat(2)6.04%
Min Revenue beat(2)5.07%
Max Revenue beat(2)7.01%
Revenue beat(4)2
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-14.21%
Max Revenue beat(4)7.01%
Revenue beat(8)3
Avg Revenue beat(8)-2.67%
Revenue beat(12)5
Avg Revenue beat(12)-1.62%
Revenue beat(16)6
Avg Revenue beat(16)-0.72%
PT rev (1m)20%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-75.86%
EPS NY rev (3m)-75.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-27.8%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-9.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF 34.85
P/OCF 11.91
P/B 1.2
P/tB 2.27
EV/EBITDA 24.74
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)0.03
FCFY2.87%
OCF(TTM)0.09
OCFY8.4%
SpS1.74
BVpS0.89
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.58%
ROE -42.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.94%
FCFM 1.76%
ROA(3y)-36.52%
ROA(5y)-32.04%
ROE(3y)-56.82%
ROE(5y)-44.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.64%
GM growth 5Y-15.56%
F-Score4
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.96
Debt/EBITDA 1.99
Cap/Depr 63.45%
Cap/Sales 3.4%
Interest Coverage N/A
Cash Conversion 297.34%
Profit Quality N/A
Current Ratio 3.7
Quick Ratio 3.69
Altman-Z -3.83
F-Score4
WACC9.57%
ROIC/WACCN/A
Cap/Depr(3y)49.02%
Cap/Depr(5y)92.75%
Cap/Sales(3y)2.21%
Cap/Sales(5y)13.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
EPS Next Y27.75%
EPS Next 2Y28.29%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y203.02%
Revenue growth 5Y151.62%
Sales Q2Q%-7.4%
Revenue Next Year-23.19%
Revenue Next 2Y-15.77%
Revenue Next 3Y-17.34%
Revenue Next 5YN/A
EBIT growth 1Y54.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.07%
EBIT Next 3Y30.79%
EBIT Next 5YN/A
FCF growth 1Y130.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y332.92%
OCF growth 3YN/A
OCF growth 5YN/A

VERIFYME INC / VRME FAQ

Can you provide the ChartMill fundamental rating for VERIFYME INC?

ChartMill assigns a fundamental rating of 3 / 10 to VRME.


What is the valuation status of VERIFYME INC (VRME) stock?

ChartMill assigns a valuation rating of 2 / 10 to VERIFYME INC (VRME). This can be considered as Overvalued.


What is the profitability of VRME stock?

VERIFYME INC (VRME) has a profitability rating of 1 / 10.


What is the financial health of VERIFYME INC (VRME) stock?

The financial health rating of VERIFYME INC (VRME) is 5 / 10.